Publications
Partners
San Francisco - Intel plans to use wearable gadgets such as smart watches to monitor patients with Parkinson's disease and collect data that can be shared with researchers.
On Wednesday, the chip maker said it is teaming up with the Michael J Fox Foundation, established by the actor and Parkinson's sufferer in 2000, to conduct a multi-phase research study of the neurodegenerative brain disease.
An estimated five million people globally have been diagnosed with Parkinson's, the second-most-common neurodegenerative disease after Alzheimer's.
The initial goal is to determine the feasibility of using wearable devices to monitor patients remotely and store that data in an open system that can be accessed by scientists.
In the next phase of the study, which will likely kick off later in 2014, the foundation will set aside funds to explore how patients are responding to medication. Participants will be monitored via an array of wearable devices.
Precise measurements
"As more of these devices hit the market, we can collect objective measurements and determine the efficacy of new therapeutics," said Sohini Chowdhury, a senior vice president for research partnerships at the foundation.
Clinical trials have been far too "subjective" in the past, she said. For instance, a patient might inform her doctor that she felt a tremor for several minutes, when it actually lasted a matter of seconds. In the future, Chowdhury hopes patients and their doctors will have more precise measurements via wearable devices about the "frequency and severity" of symptoms.
Chowdhury said the foundation will continue to raise funding to cover the costs of providing wearable devices to patients.
By using such devices, the foundation and other research groups can tap into a broader pool of patients for clinical trials, Chowdhury said. Today, many people with Parkinson's disease are unable to participate in clinical trials because they do not live near a research facility.
But wearable devices offer a convenient way to track patients from their work or homes, allowing people in the most rural parts of the country to participate.
As it expands beyond the PC arena, Intel hopes to capture a share of the growing market for big data analytics and wearable devices in the health sector.
Ron Kasabian, general manager of Intel's Big Data Solutions group, said the data centre and "Internet of Things" business units are exploring the sector.
"We're exploring how to pull data out of devices in real-time," he said. "We can mine data to improve research, and better understand the behaviours and progression of the disease."
While Intel boasts its own wearable technologies, Kasabian stressed that the Parkinson's study is device agnostic, meaning patients can test a variety of wearable gadgets.
In March, Intel completed its acquisition of Basis Science, a start-up that is best known for its wrist-band that measures the wearer's heart rate.
Intel expects to extend similar programmes to related areas of health care, as well as other industries, including manufacturing.
